Summary
Standard radioimmunoassay for insulin may substantially overestimate levels of insulin because of cross-reaction with other insulin-like molecules. We have measured concentrations of insulin, intact proinsulin and 32–33 split proinsulin using two-site monoclonal antibody based immunoradiometric assays, and of insulin by a standard radioimmunoassay (“immunoreactive insulin”) in 51 Type 2 (noninsulin-dependent) diabetic subjects in the fasting state. The relationships of these concentrations were sought with those of total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride, plasminogen activator inhibitor, blood pressure, and indices of body fat distribution. Significant relationships were apparent between concentrations of “immunoreactive insulin” as measured by standard radioimmunoassay and triglyceride (r s=0.42, p<0.001), total cholesterol (r s=0.25, p=0.038), high density lipoprotein cholesterol (r s=−0.30, p=0.018) and body mass index (r s=0.30, p=0.017), but only the relationships with triglyceride (r s=0.36, p=0.006) and body mass index (r s=0.26, p=0.034) remained significant when concentrations of immunoradiometrically measured insulin were employed. Concentrations of 32—33 split proinsulin, which comprises the major insulin-like molecule in these subjects, correlated positively with triglyceride (r s=0.33, p=0.009), total cholesterol (r s=0.23, p=0.050), and plasminogen activator inhibitor (r s=0.26, p=0.049), and negatively with high density lipoprotein cholesterol (r s=−0.29, p=0.021). Concentrations of “immunoreactive insulin” and immunoradiometric assay insulin showed significant positive correlaion with both systolic (r s=0.24, p=0.044 and r s=0.29, p=0.020 respectively), and diastolic blood pressure (r s=0.48, p<0.001 and n=0.42, p=0.001 respectively), while those of intact proinsulin and 32–33 split proinsulin correlated only with diastolic blood pressure (r s=0.33, p=0.009 and r s=0.31, p=0.014 respectively). Using multiple regression analysis, and including age, sex, race and body mass index in the analyses, concentrations of intact proinsulin and 32–33 split proinsulin, but not immunoradiometric assay insulin, were significantly related to diastolic blood pressure. When all three molecules were incorporated into a single model, only 32–33 split proinsulin was related to diastolic blood pressure (F-change=6.91, [5,43 degrees of freedom]; p=0.012). Thus, high concentrations of insulin-like molecules are associated with changes in recognised cardiovascular risk factor in patients with Type 2 (non-insulin-dependent) diabetes mellitus.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105–111
Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326–337
Olefsky JM, Farquhar JW, Reaven GM (1974) Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551–559
Laasko M, Pyörälä K, Voutilainen E, Marniemi J (1987) Plasma insulin and serum lipids and lipoprotein in middle aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 125: 611–621
Juhan-Vague I, Vague Ph, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C (1987) Relationship between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor-1. Diab Metab 13: 331–336
Vague Ph, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor levels, plasma insulin and relative body weight in normal and obese subjects. Metabolism 35: 250–253
Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54: 254–260
Stern M, Haffner SM (1986) Body fat distribution and hyperinsulinemia as risk factor in for diabetes and cardiovascular disease. Arteriosclerosis 6: 123–130
Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809–817
Temple RC, Clark P, Schneider A, Nagi DK, Hendra TJ, Yudkin JS, Hales CN (1990) Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32: 689–693
Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM (1986) Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia 29: 235–237
Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM (1987) Insulin resistance in patients of Asian Indian and European origin with non-insulin-dependent diabetes. Horm Metab Res 19: 84–85
McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA (1988) Diabetes, hyperinsulinaemia, and coronary risk factors in Bangledeshis in East London. Br Heart J 60: 390–396
World Health Organisation (1985) Diabetes mellitus: Report of a WHO Study Group. Technical Report Series No 727. WHO, Geneva
Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gray P, Luzio S, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN (1989) Sensitive and specific two-site immunoradiometric assays to human insulin, proinsulin, 65–66 split and 32–33 split proinsulin. Biochem J 260: 535–541
Verheijen JH, Chang GT, Kluft C (1984) Evidence for the occurence of a fast acting inhibitor of tissue-type plasminogen activator in human plasma. Thromb Haemostas 51: 392–395
Roeschlau P, Bernt E, Gruber W (1974) Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem 12: 226
Bucolo G, David H (1973) Quantitative determination of serum triglyceride by the use of enzymes. Clin Chem 19: 476–482
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein-cholesterol in plasma, without use of the preparative ultracentifruge. Clin Chem 18: 499–502
Hamstèn A, Wiman D, de-Faire U, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557–1563
Hamstèn A, Walladius G, Szamosi A, de-Faire U, Dahlen G, Landou C, Wiman B, Blomback M (1987) Plasminogen activator inhibitor in plasma: risk factors for recurrent myocardial infarction. Lancet II: 3–8
Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, Guerra L, Coscelli C, Butturini U (1987) Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 30: 719–723
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357
Ward WK, Lacava EC, Paquette TL, Beard JC, Wallum BJ, Porte Jr D (1987) Disproportionate elevation of immunoreactive proinsulin in type-2 (NIDDM) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698–702
Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y (1988) Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 355–360
Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN (1989) Highly specific insulin assay reveals uniform insulin deficiency in non-insulin-dependent diabetics. Lancet 1: 293–295
Gerich JE (1988) Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus. Clin Endocrinol Metab 2: 307–326
Turner RC, Holman RR, Matthews DR, Peto J (1982) Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet 1: 596–598
Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK (1988) Hyperinsulinemia, upper body obesity, and cardiovascular risk factors in non-diabetics. Metabolism 37: 338–345
Christleib AR, Krolewski AS, Warram JH, Soeldner JS (1985) Is insulin the link between hypertension and obesity? Hypertension 7 [Suppl 2]: II54-II57
Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM (1986) Blood pressure, insulin and glycemia in non-diabetic subjects. Am J Med 80: 861–864
Peevy DE, Brunner MR, Duckworth WC, Hooker CS, Frank BH (1985) Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. J Biol Chem 260: 13989–13994
Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, Galloway J, Olefsky JM (1984) The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 33: 762–770
Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D (1988) Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by human hepatocellular cell lines Hep G2. Thromb Haemostas 60: 491–494
Halkin H, Modan M, Shefi M, Almog S (1988) Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia. Hypertension 11: 71–77
Rosic NK, Standaert ML, Follet RJ (1985) The mechanism of insulin stimulation of (Na+,K+)-ATPase transport activity in muscle. J Biol Chem 260: 6206–6212
De Fronzo RA (1981) The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 21: 165–171
Landsberg L (1986) Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Quart J Med 236: 1081–1090
Pyörälä K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diab Care 2: 131–141
Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diab Care 2: 154–160
Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205–210
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagi, D.K., Hendra, T.J., Ryle, A.J. et al. The relationships of concentrations of insulin, intact proinsulin and 32–33 split proinsulin with cardiovascular risk factors in Type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33, 532–537 (1990). https://doi.org/10.1007/BF00404140
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404140